![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
R Honchel, IA Aksoy, C Szumlanski, TC Wood, DM Otterness, ED Wieben and RM Weinshilboum
Department of Pharmacology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905.
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine. Levels of TPMT activity in human tissue are controlled by a common genetic polymorphism that is an important factor responsible for individual variation in thiopurine drug toxicity and therapeutic efficacy. Our goal was to purify, to obtain a partial amino acid sequence for, and to clone and express cDNA for human TPMT as a first step in determining the molecular basis for this genetic polymorphism. Human kidney TPMT was purified, the protein was subjected to limited proteolysis, and amino acid sequence information was obtained from the resultant peptide fragments. Primers based on the amino acid sequence information were used to amplify a unique sequence from human liver cDNA by use of the polymerase chain reaction. Because TPMT has been reported to be present in the colon, T84 human colon carcinoma cells were studied and were found to express TPMT activity with biochemical properties similar to those of the human kidney and liver enzymes. Oligonucleotide probes based on the human kidney TPMT amino acid sequence were then used to screen a T84 human colon carcinoma cell cDNA library. A 2.7-kilobase cDNA clone was isolated that contained an open reading frame of 735 nucleotides, which encoded a protein of 245 amino acids. The deduced amino acid sequence of the encoded protein included one 24- and two separate 12-amino acid sequences identical to those obtained by sequencing proteolytic fragments of purified human kidney TPMT. Transcripts were made in vitro from the open reading frame of the cDNA clone. These transcripts were translated in a rabbit reticulocyte lysate system, and the resulting translation product comigrated with human kidney TPMT in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The T84 cell cDNA clone, truncated within the 3' untranslated region at an Sstl restriction site, was then used to create an expression construct with the eukaryotic expression vector P91023(B), and this construct was used to transfect COS-1 cells. The transfected cells expressed a high level of TPMT enzymatic activity, and this activity displayed a pattern of inhibition by TPMT inhibitors identical to that of human kidney and T84 human colon carcinoma cell TPMT. Cloning of cDNA for this important drug-metabolizing enzyme may make it possible to define the molecular basis of the TPMT genetic polymorphism in humans.
This article has been cited by other articles:
|
|
 |
|
  T. Dervieux, G. Meyer, R. Barham, M. Matsutani, M. Barry, R. Boulieu, B. Neri, and E. Seidman Liquid Chromatography-Tandem Mass Spectrometry Analysis of Erythrocyte Thiopurine Nucleotides and Effect of Thiopurine Methyltransferase Gene Variants on These Metabolites in Patients Receiving Azathioprine/6-Mercaptopurine Therapy Clin. Chem., November 1, 2005; 51(11): 2074 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. E. Salavaggione, C. Yang, L. B. Kidd, B. A. Thomae, V. S. Pankratz, L. A. Trepanier, and R. M. Weinshilboum Cat Red Blood Cell Thiopurine S-Methyltransferase: Companion Animal Pharmacogenetics J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 617 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Wood, K. L. Johnson, S. Naylor, and R. M. Weinshilboum Cefazolin Administration and 2-Methyl-1,3,4-Thiadiazole-5-Thiol in Human Tissue: Possible Relationship to Hypoprothrombinemia Drug Metab. Dispos., October 1, 2002; 30(10): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Weinshilboum Thiopurine Pharmacogenetics: Clinical and Molecular Studies of Thiopurine Methyltransferase Drug Metab. Dispos., April 1, 2001; 29(4): 601 - 605. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. A. Coulthard, C. Howell, J. Robson, and A. G. Hall The Relationship Between Thiopurine Methyltransferase Activity and Genotype in Blasts From Patients With Acute Leukemia Blood, October 15, 1998; 92(8): 2856 - 2862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Lohr, G. R. Willsky, and M. A. Acara Renal Drug Metabolism Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-L. Tai, E. Y. Krynetski, E. G. Schuetz, Y. Yanishevski, and W. E. Evans Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): Mechanisms for the genetic polymorphism of TPMT activity PNAS, June 10, 1997; 94(12): 6444 - 6449. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
